Non-Preferred Drug Coverage Review - (Formulary Exception Criteria) - (CNF002)
Defines Cigna's approach for medical necessity review and approval of non-formulary / non-preferred prescription drugs via Product Specific Exception Criteria. Governs documentation, required trials, approval duration, and applicability across Cigna Companies and benefit plans.
No material clinical/coverage changes.
Coverage Summary
Policy Title: Non-Preferred Drug Coverage Review (Formulary Exception Criteria); Policy Number: CNF002. Status: CURRENT.
Scope: This policy defines Cigna's approach for medical necessity review and approval of non-formulary / non-preferred prescription drugs via Product Specific Exception Criteria, and governs required documentation, prior trials, approval duration, and applicability across Cigna Companies and benefit plans.
Applicability and precedence: The Coverage Policy applies to health benefit plans administered by Cigna Companies. However, a customer's specific benefit plan document (for example, Group Service Agreement, Evidence of Coverage, Certificate of Coverage, or Summary Plan Description) or controlling federal/state law supersedes this Coverage Policy where there is a conflict. In certain markets, delegated vendor guidelines may be used to support medical necessity and other coverage determinations.
Trek Health ingests and normalizes Transparency in Coverage data and payer policy updates to give provider organizations a clear view of how commercial reimbursement behaves across markets, payers, and services. Our platform transforms raw payer disclosures into structured intelligence that supports contract evaluation, payer negotiations, and service line strategy. By combining market benchmarks with ongoing policy visibility, Trek helps teams identify variability, risk, and opportunity in commercial reimbursement. The result is faster insight, stronger negotiating positions, and more informed financial decisions.